Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.
2.

Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database.

Asomaning K, Abramsky S, Liu Q, Zhou X, Sobel RE, Watt S.

Int J Clin Pract. 2016 May;70(5):380-8. doi: 10.1111/ijcp.12791. Epub 2016 Mar 29.

PMID:
27028939
3.

Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.

Renouf DJ, Zhai R, Sun B, Xu W, Cheung WY, Heist RS, Kulke MH, Cescon D, Asomaning K, Marshall AL, Li S, Christiani DC, Liu G.

J Gastroenterol Hepatol. 2013 Sep;28(9):1482-8. doi: 10.1111/jgh.12286.

PMID:
23735059
4.

Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.

Cheung WY, Zhai R, Bradbury P, Hopkins J, Kulke MH, Heist RS, Asomaning K, Ma C, Xu W, Wang Z, Hooshmand S, Su L, Christiani DC, Liu G.

Int J Cancer. 2012 Dec 1;131(11):2478-86. doi: 10.1002/ijc.27541. Epub 2012 Apr 24.

5.

Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction.

VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, Han Y, Spitz MR, Shete S, Wu X, Gaborieau V, Wang Y, McLaughlin J, Hung RJ, Brennan P, Amos CI, Christiani DC, Lin X.

Am J Epidemiol. 2012 May 15;175(10):1013-20. doi: 10.1093/aje/kwr467. Epub 2012 Feb 3.

6.

A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.

Mak RH, Alexander BM, Asomaning K, Heist RS, Liu CY, Su L, Zhai R, Ancukiewicz M, Napolitano B, Niemierko A, Willers H, Choi NC, Christiani DC.

Cancer. 2012 Jul 15;118(14):3654-65. doi: 10.1002/cncr.26667. Epub 2011 Dec 5.

7.

MTHFR polymorphisms, folate intake and carcinogen DNA adducts in the lung.

Lee MS, Asomaning K, Su L, Wain JC, Mark EJ, Christiani DC.

Int J Cancer. 2012 Sep 1;131(5):1203-9. doi: 10.1002/ijc.27338. Epub 2012 Jan 11.

8.

Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study.

Zhai R, Zhao Y, Liu G, Ter-Minassian M, Wu IC, Wang Z, Su L, Asomaning K, Chen F, Kulke MH, Lin X, Heist RS, Wain JC, Christiani DC.

Cancer. 2012 Feb 1;118(3):804-11. doi: 10.1002/cncr.26325. Epub 2011 Jul 12.

9.

Genetic associations with sporadic neuroendocrine tumor risk.

Ter-Minassian M, Wang Z, Asomaning K, Wu MC, Liu CY, Paulus JK, Liu G, Bradbury PA, Zhai R, Su L, Frauenhoffer CS, Hooshmand SM, De Vivo I, Lin X, Christiani DC, Kulke MH.

Carcinogenesis. 2011 Aug;32(8):1216-22. doi: 10.1093/carcin/bgr095. Epub 2011 May 23.

10.

Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).

Ter-Minassian M, Asomaning K, Zhao Y, Chen F, Su L, Carmella SG, Lin X, Hecht SS, Christiani DC.

Int J Cancer. 2012 Mar 15;130(6):1338-46. doi: 10.1002/ijc.26162. Epub 2011 Aug 3.

11.

Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.

Wu IC, Zhao Y, Zhai R, Liu G, Ter-Minassian M, Asomaning K, Su L, Liu CY, Chen F, Kulke MH, Heist RS, Christiani DC.

Neoplasia. 2011 Apr;13(4):386-92.

12.

Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk.

Wu IC, Zhao Y, Zhai R, Liu CY, Chen F, Ter-Minassian M, Asomaning K, Su L, Heist RS, Kulke MH, Liu G, Christiani DC.

Carcinogenesis. 2011 Apr;32(4):502-6. doi: 10.1093/carcin/bgq287. Epub 2011 Jan 6.

13.

Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO).

Boffetta P, Jayaprakash V, Yang P, Asomaning K, Muscat JE, Schwartz AG, Zhang ZF, Le Marchand L, Cote ML, Stoddard SM, Morgenstern H, Hung RJ, Christiani DC.

Cancer Causes Control. 2011 Jan;22(1):73-9. doi: 10.1007/s10552-010-9676-5. Epub 2010 Nov 12.

14.

Comparison of discriminatory power and accuracy of three lung cancer risk models.

D'Amelio AM Jr, Cassidy A, Asomaning K, Raji OY, Duffy SW, Field JK, Spitz MR, Christiani D, Etzel CJ.

Br J Cancer. 2010 Jul 27;103(3):423-9. doi: 10.1038/sj.bjc.6605759. Epub 2010 Jun 29.

15.

A Large-scale genetic association study of esophageal adenocarcinoma risk.

Liu CY, Wu MC, Chen F, Ter-Minassian M, Asomaning K, Zhai R, Wang Z, Su L, Heist RS, Kulke MH, Lin X, Liu G, Christiani DC.

Carcinogenesis. 2010 Jul;31(7):1259-63. doi: 10.1093/carcin/bgq092. Epub 2010 May 7.

16.

Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma.

Zhai R, Chen F, Liu G, Su L, Kulke MH, Asomaning K, Lin X, Heist RS, Nishioka NS, Sheu CC, Wain JC, Christiani DC.

J Clin Oncol. 2010 May 10;28(14):2445-51. doi: 10.1200/JCO.2009.26.2790. Epub 2010 Apr 12.

17.

Parity and risk of lung cancer in women.

Paulus JK, Asomaning K, Kraft P, Johnson BE, Lin X, Christiani DC.

Am J Epidemiol. 2010 Mar 1;171(5):557-63. doi: 10.1093/aje/kwp441. Epub 2010 Jan 31.

18.

Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.

Bradbury PA, Kulke MH, Heist RS, Zhou W, Ma C, Xu W, Marshall AL, Zhai R, Hooshmand SM, Asomaning K, Su L, Shepherd FA, Lynch TJ, Wain JC, Christiani DC, Liu G.

Pharmacogenet Genomics. 2009 Aug;19(8):613-25. doi: 10.1097/FPC.0b013e32832f3010.

19.

Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.

Bradbury PA, Zhai R, Ma C, Xu W, Hopkins J, Kulke MJ, Asomaning K, Wang Z, Su L, Heist RS, Lynch TJ, Wain JC, Christiani D, Liu G.

Clin Cancer Res. 2009 Jul 15;15(14):4680-5. doi: 10.1158/1078-0432.CCR-09-0192. Epub 2009 Jul 7.

20.

Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk.

Cheung WY, Zhai R, Kulke MH, Heist RS, Asomaning K, Ma C, Wang Z, Su L, Lanuti M, Tanabe KK, Christiani DC, Liu G.

Carcinogenesis. 2009 Aug;30(8):1363-7. doi: 10.1093/carcin/bgp126. Epub 2009 Jun 11.

21.

Genome-wide analysis of survival in early-stage non-small-cell lung cancer.

Huang YT, Heist RS, Chirieac LR, Lin X, Skaug V, Zienolddiny S, Haugen A, Wu MC, Wang Z, Su L, Asomaning K, Christiani DC.

J Clin Oncol. 2009 Jun 1;27(16):2660-7. doi: 10.1200/JCO.2008.18.7906. Epub 2009 May 4.

22.

p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.

Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Ma C, Xu W, Marshall AL, Heist RS, Wain JC, Lynch TJ Jr, Christiani DC, Liu G.

Clin Cancer Res. 2009 May 1;15(9):3103-9. doi: 10.1158/1078-0432.CCR-08-3120. Epub 2009 Apr 21.

23.

Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.

Bradbury PA, Zhai R, Hopkins J, Kulke MH, Heist RS, Singh S, Zhou W, Ma C, Xu W, Asomaning K, Ter-Minassian M, Wang Z, Su L, Christiani DC, Liu G.

Carcinogenesis. 2009 May;30(5):793-8. doi: 10.1093/carcin/bgp065. Epub 2009 Mar 25.

24.

p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma.

Liu G, Cescon DW, Zhai R, Zhou W, Kulke MH, Ma C, Xu W, Su L, Asomaning K, Heist RS, Wain JC, Lynch TJ, Christiani DC.

Dis Esophagus. 2010 Jan;23(1):36-9. doi: 10.1111/j.1442-2050.2009.00960.x. Epub 2009 Mar 17.

25.

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.

Heist RS, Zhou W, Wang Z, Liu G, Neuberg D, Su L, Asomaning K, Hollis BW, Lynch TJ, Wain JC, Giovannucci E, Christiani DC.

J Clin Oncol. 2008 Dec 1;26(34):5596-602. doi: 10.1200/JCO.2008.18.0406. Epub 2008 Oct 20.

26.

Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk.

Zhai R, Liu G, Asomaning K, Su L, Kulke MH, Heist RS, Nishioka NS, Lynch TJ, Wain JC, Lin X, Christiani DC.

Carcinogenesis. 2008 Dec;29(12):2330-4. doi: 10.1093/carcin/bgn210. Epub 2008 Sep 9.

27.

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer.

Ter-Minassian M, Zhai R, Asomaning K, Su L, Zhou W, Liu G, Heist RS, Lynch TJ, Wain JC, Lin X, De Vivo I, Christiani DC.

Carcinogenesis. 2008 Nov;29(11):2147-52. doi: 10.1093/carcin/bgn205. Epub 2008 Aug 29.

28.

MDM2 promoter polymorphism and pancreatic cancer risk and prognosis.

Asomaning K, Reid AE, Zhou W, Heist RS, Zhai R, Su L, Kwak EL, Blaszkowsky L, Zhu AX, Ryan DP, Christiani DC, Liu G.

Clin Cancer Res. 2008 Jun 15;14(12):4010-5. doi: 10.1158/1078-0432.CCR-07-4187.

29.

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.

Lanuti M, Liu G, Goodwin JM, Zhai R, Fuchs BC, Asomaning K, Su L, Nishioka NS, Tanabe KK, Christiani DC.

Clin Cancer Res. 2008 May 15;14(10):3216-22. doi: 10.1158/1078-0432.CCR-07-4932.

30.

Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk.

Tse D, Zhai R, Zhou W, Heist RS, Asomaning K, Su L, Lynch TJ, Wain JC, Christiani DC, Liu G.

Cancer Causes Control. 2008 Dec;19(10):1077-83. doi: 10.1007/s10552-008-9171-4. Epub 2008 May 14.

31.

VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.

Heist RS, Zhai R, Liu G, Zhou W, Lin X, Su L, Asomaning K, Lynch TJ, Wain JC, Christiani DC.

J Clin Oncol. 2008 Feb 20;26(6):856-62. doi: 10.1200/JCO.2007.13.5947.

PMID:
18281657
32.

Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.

Zhai R, Liu G, Zhou W, Su L, Heist RS, Lynch TJ, Wain JC, Asomaning K, Lin X, Christiani DC.

Clin Cancer Res. 2008 Jan 15;14(2):612-7. doi: 10.1158/1078-0432.CCR-07-1655.

33.

Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.

Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, Zhu A, Ryan DP, Christiani DC, Liu G.

Cancer. 2008 Mar 1;112(5):1037-42. doi: 10.1002/cncr.23267.

34.

Second hand smoke, age of exposure and lung cancer risk.

Asomaning K, Miller DP, Liu G, Wain JC, Lynch TJ, Su L, Christiani DC.

Lung Cancer. 2008 Jul;61(1):13-20. doi: 10.1016/j.lungcan.2007.11.013. Epub 2008 Jan 8.

35.

Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.

Liu G, Wheatley-Price P, Zhou W, Park S, Heist RS, Asomaning K, Wain JC, Lynch TJ, Su L, Christiani DC.

Int J Cancer. 2008 Feb 15;122(4):915-8.

36.

Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib.

Liu G, Gurubhagavatula S, Zhou W, Wang Z, Yeap BY, Asomaning K, Su L, Heist R, Lynch TJ, Christiani DC.

Pharmacogenomics J. 2008 Apr;8(2):129-38. Epub 2007 Mar 20.

PMID:
17375033
37.

Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.

Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, Christiani DC.

J Clin Oncol. 2007 Feb 10;25(5):479-85.

PMID:
17290055
38.

Second hand smoke exposure and survival in early-stage non-small-cell lung cancer patients.

Zhou W, Heist RS, Liu G, Asomaning K, Miller DP, Neuberg DS, Wain JC, Lynch TJ, Christiani DC.

Clin Cancer Res. 2006 Dec 1;12(23):7187-93.

39.

The association between body mass index and osteoporosis in patients referred for a bone mineral density examination.

Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS.

J Womens Health (Larchmt). 2006 Nov;15(9):1028-34.

PMID:
17125421
40.

Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.

Zhou W, Heist RS, Liu G, Neuberg DS, Asomaning K, Su L, Wain JC, Lynch TJ, Giovannucci E, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2239-45.

41.

An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma.

Miller DP, Asomaning K, Liu G, Wain JC, Lynch TJ, Neuberg D, Su L, Christiani DC.

Cancer. 2006 Oct 1;107(7):1570-7.

42.

Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients.

Zhou W, Heist RS, Liu G, Park S, Neuberg DS, Asomaning K, Wain JC, Lynch TJ, Christiani DC.

Lung Cancer. 2006 Sep;53(3):375-80. Epub 2006 Jun 30.

PMID:
16814423
43.

Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana.

Armah HB, Narter-Olaga EG, Adjei AA, Asomaning K, Gyasi RK, Tettey Y.

J Med Microbiol. 2006 Jun;55(Pt 6):765-70.

PMID:
16687597
44.

Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.

Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC.

Carcinogenesis. 2006 May;27(5):1024-9. Epub 2005 Nov 25.

PMID:
16311244

Supplemental Content

Loading ...
Support Center